RLAY vs. COUR

Last updated Aug 1, 2026

RLAY (Relay Therapeutics, Inc.) and COUR (Coursera, Inc.) are both stocks. RLAY operates in Biotechnology (Healthcare), while COUR operates in Education & Training Services (Consumer Defensive). Over the past 5 years, RLAY returned -10.31%/yr vs -31.65%/yr for COUR. Their 0.28 correlation means their historical movements had little consistent relationship.

Performance

RLAY vs. COUR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Relay Therapeutics, Inc. (RLAY) and Coursera, Inc. (COUR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RLAY achieves a 122.58% return, which is significantly higher than COUR's -27.85% return.

RLAY

• 1D: -3.19%
• 1M: 0.97%
• 6M: 145.82%
• YTD: 122.58%
• 1Y: 460.42%
• 3Y*: 16.50%
• 5Y*: -10.31%
• 10Y*: —
• ALL TIME*: -9.75%

COUR

• 1D: 0.76%
• 1M: -10.00%
• 6M: -12.38%
• YTD: -27.85%
• 1Y: -56.37%
• 3Y*: -30.42%
• 5Y*: -31.65%
• 10Y*: —
• ALL TIME*: -31.19%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
COUR Coursera, Inc.	$47.09M	$38.50M	$40.73M
RLAY Relay Therapeutics, Inc.	$42.00M	$52.39M	$63.55M

RLAY vs. COUR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
RLAY Relay Therapeutics, Inc.	122.58%	105.34%	-62.58%	-26.31%	-51.35%	-13.69%
COUR Coursera, Inc.	-27.85%	-13.41%	-56.12%	63.74%	-51.60%	-37.33%

Correlation

The correlation between RLAY and COUR is 0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.01
Correlation (3Y) Balances recent behavior with more history.	0.16
Correlation (5Y) Shows whether the relationship held over a longer period.	0.28
Correlation (All Time) Calculated using the full available price history since Mar 31, 2021	0.28

Over the past year, the correlation between RLAY and COUR has dropped to 0.01 - well below their long-term average of 0.28, suggesting their price drivers have been diverging.

Fundamentals

Market Cap RLAY : $3.30B COUR : $975.00M
EPS RLAY : -$1.56 COUR : -$0.78
PS Ratio RLAY : 307.94 COUR : 1.05
PB Ratio RLAY : 5.27 COUR : 0.92
Total Revenue (TTM) RLAY : $10.68M COUR : $885.40M
Gross Profit (TTM) RLAY : $6.33M COUR : $494.80M
EBITDA (TTM) RLAY : -$285.68M COUR : -$115.70M

Return for Risk

RLAY vs. COUR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

RLAY

RLAY Risk / Return Rank: 99
RLAY Sharpe Ratio Rank: 100
RLAY Sortino Ratio Rank: 99
RLAY Omega Ratio Rank: 97
RLAY Calmar Ratio Rank: 99
RLAY Martin Ratio Rank: 99

COUR

COUR Risk / Return Rank: 6
COUR Sharpe Ratio Rank: 4
COUR Sortino Ratio Rank: 5
COUR Omega Ratio Rank: 6
COUR Calmar Ratio Rank: 4
COUR Martin Ratio Rank: 11

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

RLAY vs. COUR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Relay Therapeutics, Inc. (RLAY) and Coursera, Inc. (COUR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RLAY	COUR	Difference
Sharpe ratio: Return per unit of total volatility	6.17	-1.04	+7.21
Sortino ratio: Return per unit of downside risk	5.06	-1.62	+6.68
Omega ratio: Gain probability vs. loss probability	1.60	0.79	+0.80
Calmar ratio: Return relative to maximum drawdown	15.58	-0.97	+16.55
Martin ratio: Return relative to average drawdown	44.72	-1.32	+46.04

RLAY vs. COUR - Sharpe Ratio Comparison

The current RLAY Sharpe Ratio is 6.17, which is higher than the COUR Sharpe Ratio of -1.04. The chart below compares the historical Sharpe Ratios of RLAY and COUR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RLAY vs. COUR - Drawdown Comparison

The maximum RLAY drawdown since its inception was -96.75%, which is greater than COUR's maximum drawdown of -91.22%. Use the drawdown chart below to compare losses from any high point for RLAY and COUR.

Drawdown Indicators

	RLAY	COUR	Difference
Max Drawdown Largest peak-to-trough decline	-96.75%	-91.22%	-5.53%
Max Drawdown (1Y) Largest decline over 1 year	-28.15%	-59.92%	+31.77%
Max Drawdown (3Y) Largest decline over 3 years	-83.43%	-75.81%	-7.62%
Max Drawdown (5Y) Largest decline over 5 years	-94.65%	-88.25%	-6.40%
Current Drawdown Current decline from peak	-69.40%	-90.84%	+21.44%
Average Drawdown Average peak-to-trough decline	-69.15%	-73.44%	+4.29%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.79%	44.01%	-34.22%

Volatility

RLAY vs. COUR - Volatility Comparison

The current volatility for Relay Therapeutics, Inc. (RLAY) is 15.29%, while Coursera, Inc. (COUR) has a volatility of 19.02%. This indicates that RLAY experiences smaller price fluctuations and is considered to be less risky than COUR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RLAY	COUR	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.29%	19.02%	-3.73%
Volatility (6M) Calculated over the trailing 6-month period	47.60%	45.44%	+2.16%
Volatility (1Y) Calculated over the trailing 1-year period	71.21%	56.24%	+14.97%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	78.64%	59.25%	+19.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	77.36%	60.31%	+17.05%

Dividends

RLAY vs. COUR - Dividend Comparison

Neither RLAY nor COUR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both RLAY and COUR in my portfolio?

RLAY and COUR have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RLAY or COUR?

COUR has higher volatility (19.02%) compared to RLAY (15.29%). In terms of maximum drawdown, RLAY dropped -96.75% vs COUR's -91.22%.

Which has better risk-adjusted returns?

RLAY currently has the higher Sharpe Ratio (6.17 vs -1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.